- Work address
-
C. Heymanslaan 10
9000 Gent - Sylvie.Rottey@UGent.be
- ORCID iD
-
https://orcid.org/0000-0003-2060-3725
Show
Sort by
-
Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer
-
- journalArticle
- open access
Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial
-
- journalArticle
- open access
Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer
-
- journalArticle
- A1
- open access
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy
-
A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder : is there a link between metastasis and factor deficiency in solid tumors?
-
Turning the tide : clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck
-
Distant metastases in head and neck cancer
(2017) HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 39(9). p.1733-1743 -
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies
-
A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy
-
- journalArticle
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response